ArticleCureus2026
Kaposi Sarcoma in an Allograft Kidney Presenting as Acute Kidney Injury With No Cutaneous Lesions: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Kaposi sarcoma in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment and prevention.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kaposi sarcoma (KS) is an angioproliferative neoplasm linked to human herpesvirus-8 (HHV-8) and occurs more frequently in immunosuppressed patients, including kidney transplant recipients. While KS typically manifests cutaneously, visceral disease represents an uncommon presentation. Visceral KS involving the allograft kidney in patients with a previous renal transplant is an exceedingly rare finding that has seldom been reported. Herein, we report the case of a 66-year-old man with a history of kidney transplant who was found to have biopsy-confirmed, HHV-8-positive visceral KS involving the renal allograft less than one year post transplant, without cutaneous involvement. The patient's clinical course was marked by severe vasculature obstruction, bowel ischemia, and sepsis as a result of his disease burden, culminating in death despite prompt withdrawal of immunosuppression, highlighting the rarity and severity of allograft-associated KS. The severe manifestations of this patient's disease underscore the need for heightened vigilance when treating our immunosuppressed population to ensure appropriate and prompt care is given.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.